US2016206709A1PendingUtilityA1
Antimicrobial composition comprising pyrogenic silica and serrathopeptidase and uses thereof
Est. expiryJul 12, 2027(~1 yrs left)· nominal 20-yr term from priority
A61P 31/04A61P 31/00A61P 1/04A61P 17/02A61L 26/0066A61L 15/46A61L 26/0047A61L 26/0004A61L 15/44A61L 15/38A61L 2300/404C12Y 304/2404A61K 9/0014A61K 9/1676A61L 26/0095A61K 38/4886A61K 47/02A61L 15/18A61L 2300/254
40
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods are provided for treatment of wounds using a complex antimicrobial sorption composition possessing the necrolytic effect for treating the purulent wounds, the trophic ulcers, the wounds, and the infiltrates with the significant necrotic and exudative components represents the silica sorbent with the immobilized drug. Pyrogenic silica is used as a siliceous sorbent, and serrathiopeptidase as a drug.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . An antimicrobial composition comprising 90 to 99% by weight fine pyrogenic silica having particle sizes ranging from about 4 nm to about 100 nm, with 1 to 10% by weight serrathiopeptidase immobilized thereon, said composition being in the form of a dry powder.
2 . An antimicrobial composition consisting essentially of 90 to 99% by weight fine pyrogenic silica having particle sizes ranging from about 4 nm to about 100 nm, with 1 to 10% by weight serrathiopeptidase immobilized thereon, said composition being in the form of a dry powder.
3 . An antimicrobial composition consisting of 90 to 99% by weight fine pyrogenic silica having particle sizes ranging from about 4 nm to about 100 nm, with 1 to 10% by weight serrathiopeptidase immobilized thereon, said composition being in the form of a dry powder.Join the waitlist — get patent alerts
Track US2016206709A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.